Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
1.75
Dollar change
-0.02
Percentage change
-1.13
%
Index- P/E- EPS (ttm)-0.12 Insider Own5.84% Shs Outstand26.35M Perf Week15.89%
Market Cap46.45M Forward P/E- EPS next Y-0.18 Insider Trans0.00% Shs Float24.99M Perf Month10.06%
Income-2.98M PEG- EPS next Q-0.07 Inst Own24.27% Short Float1.05% Perf Quarter20.69%
Sales19.63M P/S2.37 EPS this Y13.00% Inst Trans-4.85% Short Ratio1.32 Perf Half Y34.62%
Book/sh1.23 P/B1.42 EPS next Y22.73% ROA-10.35% Short Interest0.26M Perf Year44.63%
Cash/sh0.76 P/C2.29 EPS next 5Y15.00% ROE-14.18% 52W Range1.06 - 3.97 Perf YTD-1.13%
Dividend Est.- P/FCF- EPS past 5Y11.68% ROI-9.11% 52W High-55.92% Beta1.55
Dividend TTM- Quick Ratio4.59 Sales past 5Y-4.67% Gross Margin81.80% 52W Low65.09% ATR (14)0.12
Dividend Ex-Date- Current Ratio4.71 EPS Y/Y TTM78.64% Oper. Margin-26.99% RSI (14)64.95 Volatility10.05% 7.26%
Employees69 Debt/Eq0.02 Sales Y/Y TTM-25.06% Profit Margin-15.20% Recom1.00 Target Price4.83
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q68.98% Payout- Rel Volume1.07 Prev Close1.77
Sales Surprise11.54% EPS Surprise19.61% Sales Q/Q-14.26% EarningsMay 15 BMO Avg Volume199.34K Price1.75
SMA2015.82% SMA509.72% SMA2001.67% Trades Volume212,348 Change-1.13%
Date Action Analyst Rating Change Price Target Change
Jan-18-22Downgrade Guggenheim Buy → Neutral
Apr-22-21Initiated Guggenheim Buy $24
Mar-23-21Initiated BTIG Research Buy $25
Feb-26-21Initiated Oppenheimer Outperform $27
Jan-29-21Initiated Cantor Fitzgerald Overweight $19
Dec-03-20Initiated B. Riley Securities Buy $15
Feb-05-20Initiated JMP Securities Mkt Outperform $15
Jan-09-20Initiated Lake Street Buy $14
Dec-09-08Reiterated Canaccord Adams Buy $5 → $3.50
Aug-01-08Reiterated MDB Capital Group Buy $5.50 → $6
Today 07:00AM
May-16-24 03:01AM
May-15-24 11:52AM
08:00AM
07:57AM
09:49AM Loading…
May-08-24 09:49AM
May-02-24 08:00AM
Apr-11-24 08:00AM
Apr-09-24 08:00AM
Apr-08-24 04:29PM
Apr-03-24 08:00AM
Apr-02-24 08:00AM
Mar-19-24 09:00AM
Mar-14-24 02:00PM
Mar-13-24 08:46AM
07:01AM Loading…
07:01AM
Mar-12-24 04:22PM
04:01PM
Mar-01-24 07:30AM
Feb-28-24 08:05AM
Feb-27-24 09:05AM
08:05AM
Feb-06-24 08:00AM
Jan-30-24 08:00AM
Dec-18-23 08:00AM
Dec-05-23 06:00AM
Nov-28-23 08:00AM
Nov-27-23 08:00AM
Nov-22-23 08:12AM
Nov-20-23 08:00AM
10:56AM Loading…
Nov-14-23 10:56AM
08:00AM
Nov-13-23 04:06PM
04:01PM
Oct-30-23 08:00AM
Oct-24-23 04:03PM
Oct-23-23 08:01AM
Oct-08-23 07:19PM
Sep-01-23 05:07AM
Aug-27-23 11:53AM
Aug-16-23 08:00AM
Aug-15-23 07:58AM
Aug-14-23 05:48PM
04:01PM
08:00AM
Aug-07-23 11:49AM
Jul-31-23 08:00AM
Jul-25-23 09:34PM
Jul-23-23 09:49AM
Jul-18-23 08:00AM
Jul-12-23 08:00AM
Jul-10-23 08:00AM
Jul-07-23 02:30PM
Jun-25-23 02:17PM
Jun-08-23 06:31AM
May-18-23 04:40PM
08:00AM
May-16-23 11:13AM
May-15-23 05:25PM
04:22PM
04:01PM
May-11-23 08:00AM
May-03-23 08:00AM
May-01-23 08:00AM
Apr-25-23 08:00AM
Apr-20-23 08:00AM
Apr-17-23 08:00AM
Apr-07-23 04:28PM
Apr-06-23 06:08AM
Apr-05-23 06:11AM
Apr-04-23 08:00AM
Mar-30-23 08:26AM
Mar-28-23 05:15PM
04:01PM
07:47AM
Mar-23-23 08:00AM
Mar-14-23 03:42PM
Mar-13-23 08:30AM
08:00AM
Mar-01-23 08:00AM
Feb-23-23 10:14AM
Feb-12-23 09:12AM
Feb-09-23 08:00AM
Jan-23-23 08:00AM
Jan-11-23 08:00AM
Dec-30-22 07:11AM
Dec-22-22 06:00AM
Dec-09-22 09:00AM
Dec-08-22 08:00AM
Nov-28-22 08:00AM
Nov-21-22 08:00AM
Nov-19-22 07:07AM
Nov-17-22 08:02AM
Nov-15-22 04:13PM
Nov-14-22 08:00AM
Nov-10-22 05:45PM
04:03PM
04:01PM
Oct-27-22 08:40AM
Oct-19-22 07:02AM
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.